# US 2026/0226563 A1 · Compositions and methods for detecting stx nucleic acids

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0226563 A1
- Document ID: US20260226563A1
- Status: Published application
- Kind: A1
- Application number: 19/151,258
- Filed: 2024-01-29
- Published: 2026-08-06
- Earliest claimed: 2023-01-31
- Assignees: Gen-Probe Incorporated
- Applicants: Gen-Probe Incorporated
- Inventors: Pasi M.J. PIIPARINEN; Minna M. MAUNULA
- Web page: https://patentgrep.com/patent/US20260226563A1

## CPC

- C12Q 1/689: for bacteria
- C12Q 2600/156: Polymorphic or mutational markers
- C12Q 2600/16: Primer sets for multiplex assays
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES

## Abstract

Disclosed are nucleic acid oligomers, including amplification oligomers, detection probes, and combinations thereof, for detection of one or more gastrointestinal pathogens expressing shiga toxin (stx). Also disclosed are methods of specific nucleic acid amplification and detection, including multiplex assays, using the disclosed oligomers, as well as corresponding reaction mixtures and kits.

## Claims

### Claim 1

A multiplex method for determining the presence or absence one or more variants of a stx target nucleic acid in a sample, said method comprising:
a. contacting a sample, said sample suspected of containing a stx target nucleic acid with a plurality of stx-specific amplification oligomers for amplifying a target region of the stx target nucleic acid, wherein:
i. the plurality of stx-specific amplification oligomers comprises first, second, third, fourth, fifth, and sixth oligomers respectively comprising target-hybridizing sequences consisting of the nucleotide sequences of: (i) SEQ ID NO: 29; (ii) SEQ ID NO: 5; (iii) SEQ ID NO: 23; (iv) SEQ ID NO: 26; (v) SEQ ID NO: 33; and (vi) SEQ ID NO: 40;
ii. the plurality of stx-specific amplification oligomers comprises first, second, third, fourth, and fifth oligomers respectively comprising target-hybridizing sequences consisting of the nucleotide sequences of: (i) SEQ ID NO: 14; (ii) SEQ ID NO: 15; (iii) SEQ ID NO: 18; (iv) SEQ ID NO: 30; and (v) SEQ ID NO: 20;
iii. the plurality of stx-specific amplification oligomers comprises first, second, third, fourth, and fifth oligomers respectively comprising target-hybridizing sequences consisting of the nucleotide sequences of: (i) SEQ ID NO: 21; (ii) SEQ ID NO: 19; (iii) SEQ ID NO: 18; (iv) SEQ ID NO: 30; and (v) SEQ ID NO: 20;
iv. the plurality of stx-specific amplification oligomers comprises first, second, third, fourth, and fifth oligomers respectively comprising target-hybridizing sequences consisting of the nucleotide sequences of: (i) SEQ ID NO: 31 and; (ii) SEQ ID NO: 27; (iii) SEQ ID NO: 18; (iv) SEQ ID NO: 30; and (v) SEQ ID NO: 20;
v. the plurality of stx-specific amplification oligomers comprises first, second, third, fourth, and fifth oligomers respectively comprising target-hybridizing sequences consisting of the nucleotide sequences of: (i) SEQ ID NO: 36; (ii) SEQ ID NO: 27; (iii) SEQ ID NO: 18; (iv) SEQ ID NO: 30; and (v) SEQ ID NO: 20; or
vi. the plurality of stx-specific amplification oligomers comprises first, second, third, fourth, fifth, sixth, and seventh oligomers respectively comprising target-hybridizing sequences consisting of the nucleotide sequences of: (i) SEQ ID NO: 3; (ii) SEQ ID NO: 4; (iii) SEQ ID NO: 18; (iv) SEQ ID NO: 30; (v) SEQ ID NO: 20; (vi) SEQ ID NO: 1; and (vii) SEQ ID NO: 2;
b. performing an in vitro nucleic acid amplification reaction, wherein the stx target nucleic acid, if present in said sample, is used as a template for generating one or more amplification products corresponding to the stx target regions; and
c. (i) determining the sequences of the one or more amplification products, or (ii) detecting the presence or absence of the one or more amplification products using a plurality of detection probes, wherein the detection probes are specific for one or more variants of the stx target nucleic acid,
thereby determining the presence or absence of the one or more variants of the stx target nucleic acid in said sample.

### Claim 2 (depends on 1)

The method of claim 1, wherein the plurality of stx-specific amplification oligomers further comprises first, second, third, and fourth additional stx-specific amplification oligomers for amplifying the target region of the stx target nucleic acid, wherein the first, second, third, and fourth additional stx-specific amplification oligomers respectively comprise first, second, third, and fourth target-hybridizing sequences consisting of the nucleotide sequences of: (i) SEQ ID NO: 37; (ii) SEQ ID NO: 6; (iii) SEQ ID NO: 24; and (iv) SEQ ID NO: 41.

### Claim 3 (depends on 1)

The method of claim 1, wherein the plurality of detection probes comprises (i) a first detection probe comprising a target-hybridizing sequence consisting of the nucleotide sequence of SEQ ID NO: 28 or 17; or (ii) a first detection probe comprising a target-hybridizing sequence consisting of the nucleotide sequence of SEQ ID NO: 28 and an additional detection probe comprising a target-hybridizing sequence consisting of the nucleotide sequence of SEQ ID NO: 17.

### Claim 4 (depends on 3)

The method of claim 3, wherein the first detection probe comprises the nucleotide sequence of SEQ ID NO: 10.

### Claim 5 (depends on 3)

The method of claim 3, wherein the plurality of detection probes comprises a second detection probe comprising a target-hybridizing sequence consisting of the nucleotide sequence of SEQ ID NO: 22; a third detection probe comprising a target-hybridizing sequence consisting of the nucleotide sequence of SEQ ID NO: 39; a fourth detection probe comprising a target-hybridizing sequence consisting of the nucleotide sequence of SEQ ID NO: 16; a fifth detection probe comprising a target-hybridizing sequence consisting of the nucleotide sequence of SEQ ID NO: 42; a sixth detection probe comprising a target-hybridizing sequence consisting of the nucleotide sequence of SEQ ID NO: 38; and/or a seventh detection probe comprising a target-hybridizing sequence consisting of the nucleotide sequence of SEQ ID NO: 25.

### Claim 6 (depends on 5)

The method of claim 5, wherein the second detection probe comprises the nucleotide sequence of SEQ ID NO: 8; the third detection probe comprises the nucleotide sequence of SEQ ID NO: 12; the fourth detection probe comprises the nucleotide sequence of SEQ ID NO: 7; the fifth detection probe comprises the nucleotide sequence of SEQ ID NO: 13; the sixth detection probe comprises the nucleotide sequence of SEQ ID NO: 11; and/or the seventh detection probe comprises the nucleotide sequence of SEQ ID NO: 9.

### Claim at position 7

7-31. (canceled)

### Claim 32 (depends on 1)

The method of claim 1, wherein presence or absence of the one or more amplification products are detected using the plurality of detection probes.

### Claim 33 (depends on 32)

The method of claim 32, wherein each of the plurality of detection probes comprises a fluorescent label, optionally wherein each of the plurality of detection probes further comprises a quenching label.

### Claim 34

(canceled)

### Claim 35 (depends on 32)

The method of claim 32, wherein each of the plurality of detection probes is immobilized on a solid support.

### Claim 36 (depends on 35)

The method of claim 35, wherein the solid support is a microarray and detection comprises hybridization of amplified products to one or more probes immobilized on the microarray.

### Claim 37 (depends on 1)

The method of claim 1, wherein one or more of the stx-specific amplification oligomers comprises a fluorescent label.

### Claim at position 14

38-41. (canceled)

### Claim 42

A set of oligonucleotides for determining the presence or absence one or more variants of a stx target nucleic acid in a sample, said oligonucleotide set comprising a plurality of stx-specific amplification oligomers for amplifying a target region of the stx target nucleic acid, wherein:
a. the plurality of stx-specific amplification oligomers comprises first, second, third, fourth, fifth, and sixth oligomers respectively comprising target-hybridizing sequences consisting of the nucleotide sequences of: (i) SEQ ID NO: 29; (ii) SEQ ID NO: 5; (iii) SEQ ID NO: 23; (iv) SEQ ID NO: 26; (v) SEQ ID NO: 33; and (vi) SEQ ID NO: 40;
b. the plurality of stx-specific amplification oligomers comprises first, second, third, fourth, and fifth oligomers respectively comprising target-hybridizing sequences consisting of the nucleotide sequences of: (i) SEQ ID NO: 14; (ii) SEQ ID NO: 15; (iii) SEQ ID NO: 18; (iv) SEQ ID NO: 30; and (v) SEQ ID NO: 20;
c. the plurality of stx-specific amplification oligomers comprises first, second, third, fourth, and fifth oligomers respectively comprising target-hybridizing sequences consisting of the nucleotide sequences of: (i) SEQ ID NO: 21; (ii) SEQ ID NO: 19; (iii) SEQ ID NO: 18; (iv) SEQ ID NO: 30; and (v) SEQ ID NO: 20;
d. the plurality of stx-specific amplification oligomers comprises first, second, third, fourth, and fifth oligomers respectively comprising target-hybridizing sequences consisting of the nucleotide sequences of: (i) SEQ ID NO: 31 and; (ii) SEQ ID NO: 27; (iii) SEQ ID NO: 18; (iv) SEQ ID NO: 30; and (v) SEQ ID NO: 20;
e. the plurality of stx-specific amplification oligomers comprises first, second, third, fourth, and fifth oligomers respectively comprising target-hybridizing sequences consisting of the nucleotide sequences of: (i) SEQ ID NO: 36; (ii) SEQ ID NO: 27; (iii) SEQ ID NO: 18; (iv) SEQ ID NO: 30; and (v) SEQ ID NO: 20; or
f. the plurality of stx-specific amplification oligomers comprises first, second, third, fourth, fifth, sixth, and seventh oligomers respectively comprising target-hybridizing sequences consisting of the nucleotide sequences of: (i) SEQ ID NO: 3; (ii) SEQ ID NO: 4; (iii) SEQ ID NO: 18; (iv) SEQ ID NO: 30; (v) SEQ ID NO: 20; (vi) SEQ ID NO: 1; and (vii) SEQ ID NO: 2.

### Claim 43 (depends on 42)

The oligonucleotide set of claim 42, wherein the plurality of stx-specific amplification oligomers further comprises first, second, third, and fourth additional stx-specific amplification oligomers for amplifying the target region of the stx target nucleic acid, wherein the first, second, third, and fourth additional stx-specific amplification oligomers respectively comprise first, second, third, and fourth target-hybridizing sequences consisting of the nucleotide sequences of: (i) SEQ ID NO: 37; (ii) SEQ ID NO: 6; (iii) SEQ ID NO: 24; and (iv) SEQ ID NO: 41.

### Claim at position 17

44-59. (canceled)

### Claim 60 (depends on 42)

The oligonucleotide set of claim 42, further comprising a plurality of detection probes, wherein the plurality of detection probes comprises a first detection probe comprising a target-hybridizing sequence consisting of the nucleotide sequence of SEQ ID NO: 28 or 17; a second detection probe comprising a target-hybridizing sequence consisting of the nucleotide sequence of SEQ ID NO: 22; a third detection probe comprising a target-hybridizing sequence consisting of the nucleotide sequence of SEQ ID NO: 39; a fourth detection probe comprising a target-hybridizing sequence consisting of the nucleotide sequence of SEQ ID NO: 16; a fifth detection probe comprising a target-hybridizing sequence consisting of the nucleotide sequence of SEQ ID NO: 42; a sixth detection probe comprising a target-hybridizing sequence consisting of the nucleotide sequence of SEQ ID NO: 38; and a seventh detection probe comprising a target-hybridizing sequence consisting of the nucleotide sequence of SEQ ID NO: 25.

### Claim at position 19

61-63. (canceled)

### Claim 64 (depends on 60)

The oligonucleotide set of claim 60, wherein each of the plurality of detection probes is immobilized on a solid support, optionally wherein the solid support is a microarray.

### Claim 65

(canceled)

### Claim 66 (depends on 60)

The oligonucleotide set of claim 60, wherein each of the plurality of detection probes comprises a fluorescent label, optionally wherein each of the plurality of detection probes further comprises a non-fluorescent quenching label.

### Claim 67

(canceled)

### Claim 68 (depends on 42)

The oligonucleotide set of claim 42, wherein one or more of the stx-specific amplification oligomers comprises a fluorescent label.

### Claim 69 (depends on 68)

The oligonucleotide set of claim 68, wherein two or more of the stx-specific amplification oligomers comprise a fluorescent label so that each amplification product corresponding to a stx target region comprises a fluorescent label incorporated from a stx-specific amplification oligomer.

### Claim 70

(canceled)

### Claim 71

(canceled)

### Claim 72 (depends on 42)

A kit comprising the oligonucleotide set of claim 42.

### Claim 73 (depends on 42)

A reaction mixture comprising the oligonucleotide set of claim 42.
